Skip to content

(4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide

C17H25BF3NO3S — CID 153425139

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide
SMILESCC(C[C@H](c1ccc(B2OC(C)(C)C(C)(C)O2)cc1)C(F)(F)F)S(N)=O
InChIInChI=1S/C17H25BF3NO3S/c1-11(26(22)23)10-14(17(19,20)21)12-6-8-13(9-7-12)18-24-15(2,3)16(4,5)25-18/h6-9,11,14H,10,22H2,1-5H3/t11?,14-,26?/m1/s1
InChIKeyMDIMWYWBZLQLJH-RYFODTHPSA-N
MW391.26 g/mol
LogP3.03
Rot. Bonds5

About (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide

(4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide (PubChem CID 153425139) has the molecular formula C17H25BF3NO3S and a molecular weight of 391.26 g/mol. Its IUPAC name is (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide.

Molecular Properties

Compound Name(4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide
PubChem CID153425139
Molecular FormulaC17H25BF3NO3S
Molecular Weight391.26 g/mol
Exact Mass391.16
IUPAC Name(4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide
SMILESCC(C[C@H](c1ccc(B2OC(C)(C)C(C)(C)O2)cc1)C(F)(F)F)S(N)=O
InChIInChI=1S/C17H25BF3NO3S/c1-11(26(22)23)10-14(17(19,20)21)12-6-8-13(9-7-12)18-24-15(2,3)16(4,5)25-18/h6-9,11,14H,10,22H2,1-5H3/t11?,14-,26?/m1/s1
InChIKeyMDIMWYWBZLQLJH-RYFODTHPSA-N
XLogP3.03
TPSA61.55 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500391.26
LogP ≤ 53.03
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide?
The IUPAC name of (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide (CID 153425139) is (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide.
What is the SMILES notation for (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide?
The canonical SMILES for (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide is CC(C[C@H](c1ccc(B2OC(C)(C)C(C)(C)O2)cc1)C(F)(F)F)S(N)=O.
What is the InChIKey of (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide?
The InChIKey is MDIMWYWBZLQLJH-RYFODTHPSA-N. The full InChI is InChI=1S/C17H25BF3NO3S/c1-11(26(22)23)10-14(17(19,20)21)12-6-8-13(9-7-12)18-24-15(2,3)16(4,5)25-18/h6-9,11,14H,10,22H2,1-5H3/t11?,14-,26?/m1/s1.
What are the key properties of (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide?
(4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide has a molecular weight of 391.26 g/mol, XLogP of 3.03, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-5,5,5-trifluoro-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentane-2-sulfinamide is sourced from PubChem (CID 153425139), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.